Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011221
Filing Date
2021-05-13
Accepted
2021-05-13 09:07:46
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 917871
2 ex31-1.htm EX-31.1 20216
3 ex31-2.htm EX-31.2 20214
4 ex32-1.htm EX-32.1 6374
5 ex32-2.htm EX-32.2 6302
  Complete submission text file 0001493152-21-011221.txt   5756940

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crbp-20210331.xsd EX-101.SCH 42714
7 XBRL CALCULATION FILE crbp-20210331_cal.xml EX-101.CAL 63710
8 XBRL DEFINITION FILE crbp-20210331_def.xml EX-101.DEF 208542
9 XBRL LABEL FILE crbp-20210331_lab.xml EX-101.LAB 383285
10 XBRL PRESENTATION FILE crbp-20210331_pre.xml EX-101.PRE 328143
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 895374
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 21917527
SIC: 2834 Pharmaceutical Preparations